BCT — Briacell Therapeutics Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeMicro CapNeutral

Annual balance sheet for Briacell Therapeutics, fiscal year end - July 31st, USD millions except per share, conversion factor applied.

	2022 July 31st	2023 July 31st	2024 July 31st	2025 July 31st	2026 July 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	ARS	ARS	ARS	ARS	ARS
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	41	21.3	0.862	17.9	20.5
Net Total Accounts Receivable
Net Total Receivables	0.024	0.019	2.79	2.06	—
Prepaid Expenses
Total Current Assets	42.3	26.9	3.65	19.9	22
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	—	—	0.388	0.297	0.32
Net Intangible Assets
Long Term Investments
Other Long Term Assets
Total Assets	42.6	27.2	5.87	21.6	23.6
Accounts Payable
Payable / Accrued
Notes Payable / Short Term Debt
Total Current Liabilities	0.941	1.8	7.46	3.98	7.98
Long Term Debt
Total Long Term Debt
Total Debt
Minority Interest
Total Other Liabilities
Total Liabilities	32.2	30.9	8.25	3.77	7.18
Common Stock
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	10.3	-3.78	-2.38	17.9	16.4
Total Liabilities & Shareholders' Equity	42.6	27.2	5.87	21.6	23.6
Total Common Shares Outstanding